TROPHIMMUN, a 2 cohort phase II trial of the anti-PD-L1 monoclonal antibody avelumab in chemo-resistant gestational trophoblastic neoplasia (GTN) patients: Preliminary outcomes in cohort A

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; pp. viii727 - viii728
Main Authors You, B.M., Bolze, P.A., Lotz, J.-P., Massardier, J., Gladieff, L., Hajri, T., Maucort-Boulch, D., Bin, S., Roux, A., Rousset, P., Freyer, G., Golfier, F.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

Loading…
Author Freyer, G.
Massardier, J.
Bolze, P.A.
Gladieff, L.
Roux, A.
Hajri, T.
Bin, S.
You, B.M.
Rousset, P.
Lotz, J.-P.
Maucort-Boulch, D.
Golfier, F.
Author_xml – sequence: 1
  givenname: B.M.
  surname: You
  fullname: You, B.M.
  organization: CITOHL, Hospices Civiles de Lyon, Lyon, France
– sequence: 2
  givenname: P.A.
  surname: Bolze
  fullname: Bolze, P.A.
  organization: Gynécologie, Centre de Référence des Maladies Trophoblastiques, Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France
– sequence: 3
  givenname: J.-P.
  surname: Lotz
  fullname: Lotz, J.-P.
  organization: Medical Oncology, APHP, CancerEst, Tenon University Hospital, Paris, France
– sequence: 4
  givenname: J.
  surname: Massardier
  fullname: Massardier, J.
  organization: Gynécologie, Centre de Référence des Maladies Trophoblastiques, Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France
– sequence: 5
  givenname: L.
  surname: Gladieff
  fullname: Gladieff, L.
  organization: Oncologie Médicale, Institut Universitaire du Cancer -Toulouse- Oncopole, Toulouse, France
– sequence: 6
  givenname: T.
  surname: Hajri
  fullname: Hajri, T.
  organization: Gynécologie, Centre de Référence des Maladies Trophoblastiques, Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France
– sequence: 7
  givenname: D.
  surname: Maucort-Boulch
  fullname: Maucort-Boulch, D.
  organization: Biostatistics, Centre Hospitalier Lyon Sud, Pierre Bénite, France
– sequence: 8
  givenname: S.
  surname: Bin
  fullname: Bin, S.
  organization: Unité Recherche et Epidémiologie Cliniques, Pôle de Santé Publique, Lyon, France
– sequence: 9
  givenname: A.
  surname: Roux
  fullname: Roux, A.
  organization: Unité Recherche et Epidémiologie Cliniques, Pôle de Santé Publique, Lyon, France
– sequence: 10
  givenname: P.
  surname: Rousset
  fullname: Rousset, P.
  organization: Radiology, Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France
– sequence: 11
  givenname: G.
  surname: Freyer
  fullname: Freyer, G.
  organization: CITOHL, Hospices Civiles de Lyon, Lyon, France
– sequence: 12
  givenname: F.
  surname: Golfier
  fullname: Golfier, F.
  organization: Gynécologie, Centre de Référence des Maladies Trophoblastiques, Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32138003$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1P3DAUtCqqskB_QC_VO7ZSA_5Iskl7QrSFlRZYVcs5cuyXxlViR7YXaf9bf1y9BHrk9J7GM6N5nhNyZJ1FQj4wes5oLS6kTYC6GPU-5_k5zfkbsmBFWWcVzdkRWdCai2xZiPyYnITwh1Ja1rx-R44FZ6KiVCzI3-2v-83N6vb24e4LSOCgXO98hKmXAWG1guiNHMB1EHsEaaPJNt-zNYPRWacGZ9PjAW2d3oN8xGE3yhaMBdXj6DKPwYSYCPAb04zmSRC9m3rXDjJEo8Cim9JqJHy63t59hinR0MbwFTYeBzMaK_0e3C4qN2J48p4zXp6Rt50cAr5_nqfk4eeP7dVNtr6_Xl1drjPFlxXPUMtcVCUTqAosDtiSSYFCF4WoO6F5gqsyRylzKcpad1oIXrZUVmnHqhKnhM2-yrsQPHbN5M2YUjWMNocmmrmJZm6iSU0kzcdZM-3aEfV_xcvXJ8K3mYAp-aNB3wSV7laojUcVG-3MK_b_AL0noD8
CitedBy_id crossref_primary_10_1016_j_annonc_2020_02_015
ContentType Journal Article
Copyright 2018 THE AUTHORS
Copyright_xml – notice: 2018 THE AUTHORS
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
DOI 10.1093/annonc/mdy424.042
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
DatabaseTitle PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1569-8041
EndPage viii728
ExternalDocumentID 10_1093_annonc_mdy424_042
32138003
S0923753419504331
Genre Journal Article
GroupedDBID ---
-E4
.2P
.86
.I3
.XZ
.ZR
08P
0R~
0U7
1TH
23M
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
6I.
6J9
70D
AABJS
AABMN
AAEDW
AAESY
AAFTH
AAIAV
AAIYJ
AAJKP
AAJQQ
AAKAS
AAKUH
AAMVS
AAOGV
AAPNW
AAUQX
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVKL
ABZBJ
ACGFO
ACGFS
ACIMA
ACMRT
ACPQN
ACPRK
ACUFI
ACUTO
ADBBV
ADEIU
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADYVW
ADZCM
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFIYH
AFOFC
AFXEN
AGINJ
AGKEF
AGKRT
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AIKOY
AITUG
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
AQKUS
ASMCH
ASPBG
ATTQO
AVWKF
AWCFO
AXUDD
AZFZN
AZQFJ
BAWUL
BAYMD
BEYMZ
BGNMA
BGYMP
BHONS
BTRTY
BVRKM
BZKNY
C1A
CAG
CASEJ
CDBKE
CKLRP
COF
CS3
CZ4
DAKXR
DIK
DILTD
DL5
DPORF
DPPUQ
D~K
E3Z
EBS
EE~
EJD
EX3
F9B
FDB
FEDTE
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
I09
IH2
IHE
IOX
J21
KAQDR
KC5
KDC
KOM
KOP
KQ8
KSI
KSN
LAK
M-Z
M41
M49
M4Y
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOYVH
NTWIH
NU-
NU0
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OVD
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RPX
RW1
RXO
RZC
RZE
RZF
RZO
SDH
TCURE
TEORI
TJX
TMA
TR2
U2A
W8F
WOQ
WOW
X7H
YAYTL
YFH
YKOAZ
ZKX
ZXP
~91
0SF
AALRI
ADVLN
AEHUL
AFETI
AFJKZ
AFSHK
AKRWK
H13
NPM
AAYXX
CITATION
ID FETCH-LOGICAL-c2782-eda438613ec5e5c27871a3e3d5539f3d2c5e864eaa4a369dfd3326b0a89dfe883
IEDL.DBID ABVKL
ISSN 0923-7534
IngestDate Thu Sep 26 15:44:33 EDT 2024
Wed Oct 16 00:46:55 EDT 2024
Fri Feb 23 02:48:13 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2782-eda438613ec5e5c27871a3e3d5539f3d2c5e864eaa4a369dfd3326b0a89dfe883
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0923753419504331
PMID 32138003
ParticipantIDs crossref_primary_10_1093_annonc_mdy424_042
pubmed_primary_32138003
elsevier_sciencedirect_doi_10_1093_annonc_mdy424_042
PublicationCentury 2000
PublicationDate October 2018
2018-Oct
2018-10-00
PublicationDateYYYYMMDD 2018-10-01
PublicationDate_xml – month: 10
  year: 2018
  text: October 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Annals of oncology
PublicationTitleAlternate Ann Oncol
PublicationYear 2018
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
SSID ssj0006929
Score 2.3255258
SourceID crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage viii727
Title TROPHIMMUN, a 2 cohort phase II trial of the anti-PD-L1 monoclonal antibody avelumab in chemo-resistant gestational trophoblastic neoplasia (GTN) patients: Preliminary outcomes in cohort A
URI https://dx.doi.org/10.1093/annonc/mdy424.042
https://www.ncbi.nlm.nih.gov/pubmed/32138003
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGJiFeJhgfG1-6Bx4AYZrYTprsrZSNFtaughZVe4n8Fa3SSKouQ-r_xh-3c-xO42VIvCTRSb6c7pzzzznfHSFvtLGlVZJR9HURFd00oSqPOF5EjCStc92e8h2ng5n4Ok_mW6S_yYVxxyqD7_c-vfXWgdIJ2uwsF4vOjwixCYJt4RqZuryfe2SHIfrFr3On9-nnt5Mbh5zmzJfcY5y6AZvgZs5dr5e60rj5XwsmPkaC_WN5urX2HD8kuwE0Qs_L9Yhs2WqP3B-FsPhj8mf6_XQyGI5Gs_EHkMDAtb1dNbA8xzUKhkNoe3NAXQLCPUBdLujkMz2JAedgrS8cGG-pqjZrkL8tOiypYFEBWvRXTXFH7lBm1YALRoW_h8izXp7XCtE3SgWVO4nuMjLh7Zfp-B2Eeq2XhzBZ2Yu2ddhqDfVVg4q2ly1vL2PvCZkdH037AxraMlDNEE9Qa6TgGcIAqxObOFo3ltxykyQ8L7lhSM5SYaUUkqe5KQ1HjKgimeGzzTL-lGyj1u0-AcV1V5Ymi7hLCI4iZVSirZDIUKVa5Afk_cYaxdJX3yh81JwX3nSFN12BpjsgYmOv4q8pVODqcNewZ962N2_gLOYoDH_-fwxfkAeIqnzR3Pgl2W5WV_YVIpdGvQ4zE-_j_vz07BqHrfJJ
link.rule.ids 315,783,787,27581,27936,27937,45675
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJwEviG8GA-6BB0CYJraTJryVjdGytlRbi_YW-StapZFUXYbU_21_3M6xO42XIfESRSf5crqz7n7O-e4IeaeNLa2SjKKvi6jopQlVecTxIWIkaZ3r9pbvJB3MxY-T5GSL7G1qYdy1yuD7vU9vvXWgdIM2u8vFonscITZBsC3cIFNX93OHbCMa6CUdst3_-utwdO2Q05z5lnuMU7dgk9zMuZv1UlcaD_9rwcTnSLB_hKcbsefgIXkQQCP0vVyPyJatHpO745AWf0IuZ0c_p4PheDyffAIJDNzY21UDy1OMUTAcQjubA-oSEO4B6nJBp_t0FAPuwVqfOTDeUlVt1iD_WHRYUsGiArTo75riidyhzKoBl4wKfw-RZ708rRWib5QKKncT3VVkwvvvs8kHCP1az7_AdGXP2tFhqzXUFw0q2p63vL2M_adkfvBttjegYSwD1QzxBLVGCp4hDLA6sYmj9WLJLTdJwvOSG4bkLBVWSiF5mpvScMSIKpIZvtss489IB7VuXxBQXPdkabKIu4LgKFJGJdoKiQxVqkW-Qz5urFEsffeNwmfNeeFNV3jTFWi6HSI29ir-2kIFRofblj33tr3-AmcxR2H4y_9j-JbcG8zGo2I0nBy-IvcRYfkGuvEu6TSrC_saUUyj3oRdegVvGvOC
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TROPHIMMUN%2C+a+2+cohort+phase+II+trial+of+the+anti-PD-L1+monoclonal+antibody+avelumab+in+chemo-resistant+gestational+trophoblastic+neoplasia+%28GTN%29+patients%3A+Preliminary+outcomes+in+cohort+A&rft.jtitle=Annals+of+oncology&rft.au=You%2C+B.M.&rft.au=Bolze%2C+P.A.&rft.au=Lotz%2C+J.-P.&rft.au=Massardier%2C+J.&rft.date=2018-10-01&rft.issn=0923-7534&rft.volume=29&rft.spage=viii727&rft.epage=viii728&rft_id=info:doi/10.1093%2Fannonc%2Fmdy424.042&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_annonc_mdy424_042
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon